Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Neurotech Pharmaceuticals, Inc. Receives Priority Review of Biologics License Application (BLA) for NT-501 (revakinagene taroretcel) as a Treatment for Macular Telangiectasia Type 2 (MacTel)
Kontron introduces the XMC-ETH6